Cochrane in context: Rifamycins compared to isoniazid for preventing tuberculosis in HIV‐negative people at risk of active TB

Abstract Cochrane Review: Rifamycins (rifampicin, rifabutin, and rifapentine) compared to isoniazid for preventing tuberculosis in HIV‐negative people at risk of active TB Sharma SK, Sharma A, Kadhiravan T, Tharyan P. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV‐negative people at risk of active TB. Cochrane Database of Systematic Reviews 2013, Issue 7. Art. No.: CD007545. DOI: 10.1002/14651858.CD007545.pub2. This companion piece to the review, “Rifamycins (rifampicin, rifabutin, and rifapentine) compared to isoniazid for preventing tuberculosis in HIV‐negative people at risk of active TB,” contains the following pieces: The abstract of the review A commentary from one or more of the review authors, explaining why the review team felt the review was an important one to produce A review of clinical practice guidelines from the American Academy of Pediatrics, and the National Institute for Health and Care Excellence (NICE), United Kingdom Some other recently published references on this topic
Source: Evidence-Based Child Health: A Cochrane Review Journal - Category: Pediatrics Authors: Tags: Commentary Source Type: research